The lawsuit, which Fierce Healthcare disclosed, alleges the firms manufactured and sold what the complaint characterizes as modern-day snake oil: compounded oral tirzepatide tablets with no demonstrated mechanism of absorption or efficacy. MEDVi is not named as a defendant, but the complaint alleges the plaintiff purchased the pills through MEDVi, which it describes as one of dozens of consumer-facing telehealth storefronts in a network operated by OpenLoop
Keep a brief symptom diarynote the date, time of day, trigger (if identifiable), and intensityto share with your healthcare provider during check-ins
A 5 mg dose from a 10 mg/mL vial requires 0.5 mL
Safety Information Do not exceed the recommended dosage
Stones can still form in or migrate within the bile ducts, and the JAMA Internal Medicine analysis reported an association with biliary disease broadly (RR 1.55
It is important to note that you must change your tubing frequently to prevent infection